Cargando…
Clinical, Neurophysiological, and MRI Markers of Fampridine Responsiveness in Multiple Sclerosis—An Explorative Study
Objective: Persons with multiple sclerosis (PwMS), already established as responders or non-responders to Fampridine treatment, were compared in terms of disability measures, physical and cognitive performance tests, neurophysiology, and magnetic resonance imaging (MRI) outcomes in a 1-year explorat...
Autores principales: | Mamoei, Sepehr, Jensen, Henrik Boye, Pedersen, Andreas Kristian, Nygaard, Mikkel Karl Emil, Eskildsen, Simon Fristed, Dalgas, Ulrik, Stenager, Egon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576138/ https://www.ncbi.nlm.nih.gov/pubmed/34764932 http://dx.doi.org/10.3389/fneur.2021.758710 |
Ejemplares similares
-
Study protocol: randomised controlled trial evaluating exercise therapy as a supplemental treatment strategy in early multiple sclerosis: the Early Multiple Sclerosis Exercise Study (EMSES)
por: Riemenschneider, Morten, et al.
Publicado: (2021) -
Aerobic Capacity Is Not Associated with Most Cognitive Domains in Patients with Multiple Sclerosis—A Cross-Sectional Investigation
por: Langeskov-Christensen, Martin, et al.
Publicado: (2018) -
Correction: Langeskov-Christensen, M., et al. Aerobic Capacity Is Not Associated with Most Cognitive Domains in Patients with Multiple Sclerosis—A Cross-Sectional Investigation. Journal of Clinical Medicine 2018, 7, 272
por: Langeskov-Christensen, Martin, et al.
Publicado: (2019) -
Fampridine and quality of life in individuals with multiple sclerosis
por: Sagawa, Yoshimasa, et al.
Publicado: (2016) -
Managing HAM/TSP with Fampridine
por: Menna-Barreto, M Marcio
Publicado: (2014)